0001179110-20-008088.txt : 20200707
0001179110-20-008088.hdr.sgml : 20200707
20200707081157
ACCESSION NUMBER: 0001179110-20-008088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200702
FILED AS OF DATE: 20200707
DATE AS OF CHANGE: 20200707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON JOHN
CENTRAL INDEX KEY: 0001410781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37569
FILM NUMBER: 201015269
MAIL ADDRESS:
STREET 1: DENDREON CORPORATION
STREET 2: 1301 2ND AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER NAME:
FORMER CONFORMED NAME: Johnson John H
DATE OF NAME CHANGE: 20070827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Strongbridge Biopharma plc
CENTRAL INDEX KEY: 0001634432
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981130690
STATE OF INCORPORATION: L2
BUSINESS ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
BUSINESS PHONE: (610) 254-9200
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
FORMER COMPANY:
FORMER CONFORMED NAME: Cortendo AB
DATE OF NAME CHANGE: 20150219
4
1
edgar.xml
FORM 4 -
X0306
4
2020-07-02
0
0001634432
Strongbridge Biopharma plc
SBBP
0001410781
JOHNSON JOHN
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE
PA
19053
1
1
0
0
Chief Executive Officer
Ordinary Shares
2020-07-02
4
A
0
315000
0
A
522152
D
Represents a grant of restricted stock units ("RSUs"). One-half of the RSUs will vest on July 2, 2021 with the remaining one-half of the RSUs vesting on July 2, 2022, provided the Reporting Person is employed by, or providing services to, the Issuer on each vesting date. Each RSU represents a contingent right to receive one ordinary share of the Issuer.
/s/ Judith Goldberg, as attorney-in-fact
2020-07-07